TOP 10 Oncology treatment in New Haven, Connecticut

Sarah Elizabeth Schellhorn, MD is a specialized institution located at 20 York Street in New Haven, Connecticut, United States. Dr. Schellhorn is dedicated to providing expert care in breast medical oncology, supporting patients and their families through difficult diagnoses. She works closely with a team of skilled physicians including breast surgeons, radiation oncologists, and pathologists to develop evidence-based treatment plans and ensure patients understand their options. As the chief ambulatory officer of Smilow Cancer Hospital, Dr. Schellhorn oversees clinical operations at the cancer center on York Street. She is also involved with the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale School of Medicine, focusing on chemotherapy regimens for breast cancer treatment.

Tara Sanft, MD, located at 35 Park Street in New Haven, Connecticut, is a renowned institution specializing in oncology and survivorship care. Dr. Sanft, a Yale Medicine medical oncologist, is dedicated to helping patients navigate life after cancer treatment by providing personalized survivorship care plans. The Survivorship Program at Yale Cancer Center and Smilow Cancer Hospital, led by Dr. Sanft, offers a multidisciplinary approach to address common issues faced by cancer survivors, such as fear of recurrence and intimacy issues. The team, which includes a social worker, physical therapist, and nutritionist, also provides recommendations for diet, exercise, and follow-up care to empower survivors to take control of their lives. Dr. Sanft emphasizes the importance of the survivorship phase, where patients may feel lost in transition and need support in adjusting to a "new normal" after cancer. The institution also offers information on cancer treatment side effects, breast cancer symptoms and treatment, chemotherapy, and inflammatory breast cancer. With a focus on holistic care and support, Tara Sanft, MD, is dedicated to helping cancer survivors thrive beyond their diagnosis.

Dr. Shalin Kothari is a renowned hematologist and Assistant Professor of Medicine at Yale University, located at 800 Howard Avenue in New Haven, Connecticut. Dr. Kothari completed his medical training at Gujarat University in India and his residency in Internal Medicine at SUNY Upstate Medical University. He then went on to complete his fellowship in Hematology and Medical Oncology at the University at Buffalo/Roswell Park Comprehensive Cancer Center, where he was the Chief Fellow. Dr. Kothari specializes in the treatment of lymphomas, with a particular focus on aggressive forms of B-cell lymphomas such as mantle cell lymphoma. His research is dedicated to understanding the mechanisms of lymphoma therapeutics and translating that knowledge into early-phase clinical trials. He is actively involved in research at the Müschen Laboratory at Yale University, working on developing new therapies for mantle cell lymphoma.

Hari Deshpande, MD, located at 20 York Street in New Haven, Connecticut, is a medical institution specializing in the treatment of sarcomas and thyroid cancers. Dr. Deshpande, a medical oncologist, works closely with a team of specialized surgeons, endocrinologists, radiation oncologists, radiologists, pathologists, and nurses to create personalized treatment plans for each patient. With a focus on personalized medicine and the latest molecular techniques, Dr. Deshpande is dedicated to providing the best care possible for his patients. Dr. Deshpande participates in disease-specific tumor boards and is actively involved in clinical trials for sarcomas and thyroid cancers. He believes that the treatment of these cancers has advanced significantly in recent years, but there is still much more to be done in terms of research and finding effective treatments.

Dr. Kerin Adelson is a renowned doctor and Adjunct Associate Professor located at 35 Park Street in New Haven, Connecticut. Previously serving as the Chief Quality Officer for Yale Cancer Center and Smilow Cancer Hospital, Dr. Adelson is dedicated to improving care coordination and aligning care with national quality metrics. With a background in oncology from top institutions such as Yale University School of Medicine, Mount Sinai Medical Center, and Columbia Presbyterian, Dr. Adelson is committed to enhancing patient involvement in decisions about their cancer care. She is actively involved in national committees such as the Southwest Oncology group Cancer Delivery Committee and the American Society of Clinical Oncology Health Information Technology Committee. Visit Dr. Kerin Adelson for top-notch healthcare and expertise in cancer treatment.